/ALNFL.PA
ALNFL.PA Stock - NFL Biosciences S.A.
Healthcare|BiotechnologyPAR
$1.16+1.76%
+$0.02 (+1.76%) • Dec 23
62
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.53
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.70
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $1.27
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ALNFL.PA
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1.15 – $1.17
TARGET (TP)$1.33
STOP LOSS$1.07
RISK/REWARD1:2.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.25
52W High$2.10
52W Low$0.85
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $46 | $200,011 | N/A | $39 | $3 |
| Gross Profit | $-67,143 | $-56,064 | $-2,235,726 | $-530,733 | $-169,359 |
| Gross Margin | -145963.0% | -28.0% | N/A | -1360853.8% | -5645300.0% |
| Operating Income | $-2,790,091 | $-4,430,420 | $-3,013,533 | $-901,867 | $-318,028 |
| Net Income | $-2,080,839 | $-3,745,476 | $-2,443,485 | $-978,244 | $-266,486 |
| Net Margin | -4523563.0% | -1872.6% | N/A | -2508317.9% | -8882866.7% |
| EPS | $-0.21 | $-0.46 | $-0.47 | $-0.19 | $-0.05 |
Company Overview
NFL Biosciences SA, a biotechnology company, develops natural addiction withdrawal solutions for smokers. Its natural drug candidate in pipeline to cure tobacco addiction include NFL-101, a tobacco extract that is in Phase III clinical trial targeting smoking addiction; NFL-201, a cannabis and tobacco extract, which is in preclinical stage; and NFL-301, a botanical extract (traditional Chinese medicine) that is in preclinical stage. The company was incorporated in 2006 and is based in Castelnau-le-Lez, France.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
ALNFL.PABeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.14
Q4 2024
EPS Surprise History
Q2 21
No data
Q2 22
No data
Q4 22
No data
Q2 23
No data
Q4 23
No data
Q3 24
No data
Q4 24
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Oct 16, 2025 | — | — | — | — |
Q2 2025 | Apr 11, 2025 | — | — | — | — |
Q4 2024 | Dec 31, 2024 | — | $-0.14 | — | — |
Q3 2024 | Sep 27, 2024 | — | — | — | — |
Q3 2024 | Aug 30, 2024 | — | $-0.08 | — | — |
Q1 2024 | Mar 29, 2024 | — | — | — | — |
Q4 2023 | Dec 30, 2023 | — | $-0.20 | — | — |
Q4 2023 | Oct 6, 2023 | — | — | — | — |
Q2 2023 | Jun 20, 2023 | — | $-0.28 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.26 | — | — |
Q2 2022 | Jun 29, 2022 | — | $-0.20 | — | — |
Q1 2022 | Mar 28, 2022 | — | — | — | — |
Q4 2021 | Oct 4, 2021 | — | — | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.06 | — | — |
Latest News
Loading news...
Frequently Asked Questions about ALNFL.PA
What is ALNFL.PA's current stock price?
NFL Biosciences S.A. (ALNFL.PA) is currently trading at $1.16 per share. The stock has moved +1.76% today.
What is the analyst price target for ALNFL.PA?
No analyst price targets are currently available for this stock.
What sector is NFL Biosciences S.A. in?
NFL Biosciences S.A. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the PAR exchange.
What is ALNFL.PA's market cap?
NFL Biosciences S.A. has a market capitalization of $0.01 billion, making it a small-cap company.
Does ALNFL.PA pay dividends?
No, NFL Biosciences S.A. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAELIS.PA
Aelis Farma S.A.
$1.07
Mkt Cap: $0.0B
ALBIO.PA
Biosynex S.A.
$0.58
Mkt Cap: $0.0B
ALINS.PA
Intrasense S.A.
$0.25
Mkt Cap: $0.0B
ALPAT.PA
Plant Advanced Technologies S.A.
$8.46
Mkt Cap: $0.0B
ALPRE.PA
Predilife S.A.
$3.39
Mkt Cap: $0.0B
ALTHX.PA
THX Pharma
$2.02
Mkt Cap: $0.0B
ALTME.PA
TME Pharma N.V.
$0.06
Mkt Cap: $0.0B
ALVAL.PA
Valbiotis S.A.
$0.69
Mkt Cap: $0.0B
POXEL.PA
Poxel S.A.
$0.24
Mkt Cap: $0.0B
SIGHT.PA
GenSight Biologics S.A.
$0.11
Mkt Cap: $0.0B
Explore stocks similar to ALNFL.PA for comparison